U.S. Auto Components Stock News

Radian Group Inc. reported second-quarter 2026 results, with revenue rising to US$574.96 million from US$298.55 million a year earlier, while net income declined to US$115.91 million and diluted earnings per share from continuing operations eased to US$0.87. Despite the higher revenue and a small positive surprise versus consensus, adjusted earnings of US$1.14 per share fell short of analyst expectations, highlighting pressure on profitability. Next, we’ll examine how this earnings miss amid...

What CNX Resources’ latest update means for shareholders CNX Resources (CNX) has just wrapped up a long running buyback program, repurchasing roughly 65% of its shares since 2018, alongside fresh 2026 production guidance and its latest quarterly earnings. See our latest analysis for CNX Resources. Against this backdrop of buybacks, updated production guidance and mixed quarterly figures, CNX Resources’ share price has eased 3.1% over the last day but still sits on a 1 year total shareholder...

How Terex’s Mixed Q2 2026 Earnings Frame the Latest Stock Debate Terex (TEX) released Q2 2026 results that paired higher quarterly sales and net income with weaker earnings over the first half of the year. That contrast is now central to how investors view the stock. See our latest analysis for Terex. Terex’s share price has climbed 20.03% year to date to around $66, with a 37.69% total shareholder return over the past year, suggesting recent momentum has been positive even after a 5.07% 1...

Cumberland Pharmaceuticals stock cooled 2.8% today after a strong multi month run, even as the real story landed far from the trading screen. The headline is not the quarterly loss; it is the pivot. Q2 still showed a US$3.1 million operating loss on ongoing operations and a US$4.1 million net loss once discontinued activities are included. Yet the recently closed US$100 million divestiture and US$1.50 per share special dividend now frame Cumberland as a cash rich, development focused biotech...

Ingersoll Rand (IR) is back in focus after its second quarter 2026 earnings update, its new full year revenue growth guidance of 4.5% to 6.5%, and continued capital returns via buybacks and dividends. See our latest analysis for Ingersoll Rand. Ingersoll Rand's recent guidance update, Lone Star Blower acquisition, and ongoing buybacks appear to sit behind a solid run of momentum, with a 30 day share price return of 11.62% and a 1 year total shareholder return of 17.80% pointing to both short...

Why GATX stock is back in focus after earnings and guidance update GATX (GATX) is attracting fresh attention after reporting higher second quarter revenue and net income, alongside updated 2026 earnings guidance that gives investors a clearer view of expected full year profitability. See our latest analysis for GATX. Alongside the earnings and higher 2026 guidance, GATX stock has cooled slightly in the very near term, with the 1 day and 7 day share price returns both declining a little over...

Oscar Health (NYSE:OSCR) has joined the initial industry cohort for ICHRAx, a new platform focused on standardizing individual coverage health reimbursement arrangement enrollment and billing. ICHRAx is designed to simplify how employers and employees manage ICHRA plans across insurers using a common technology framework. Participation in the ICHRAx launch positions Oscar Health as an early contributor to efforts to streamline administration in the individual coverage market. The move is...

Baxter International has climbed back into positive territory over the last year, yet the stock still carries a long 5 year track record of losses. Investors are asking whether the recent rebound and fresh optimism around the business are now fully reflected in the share price, or if there is still a margin between market price and intrinsic value based on a Discounted Cash Flow (DCF) view. Over the last 5 years Baxter International has declined 59.1%, which means the stock is coming into...

In July 2026, the Metropolitan Washington Airports Authority, United Airlines, and the U.S. Department of Transportation announced a more than US$20.00 billion, decade-long modernization of Washington Dulles International Airport, adding over 5.00 million square feet of new and upgraded facilities while retiring the airport’s mobile lounge vehicles. This large-scale capital program deepens United’s role at a key U.S. gateway, with new United gates, expanded lounge capacity, and upgraded...

In July 2026, Orchid Island Capital, Inc. reported second-quarter 2026 results showing net income of US$89.19 million and basic earnings per share from continuing operations of US$0.44, compared with a loss a year earlier. Over the same period, the company also continued its long-running share repurchase effort, buying back more than one million shares and completing a program that has retired very large portion of its outstanding stock since 2015. Next, we’ll examine how this sharp swing to...

Sprouts Farmers Market (SFM) just packed a lot into a single update. The company reported second quarter results, issued fresh guidance for 2026, expanded its store opening plan, and announced the completion of a share repurchase tranche. See our latest analysis for Sprouts Farmers Market. Sprouts Farmers Market shares trade at US$85.12 after a recent 7.53% 7 day share price return, while the 1 year total shareholder return has fallen 43.54% and the 5 year total shareholder return is 244.48%...

Kymera Therapeutics stock edged up about 1% to US$105.48 after the Q2 print, a muted move for a biotech reporting US$65m in collaboration revenue and another quarter of sizeable losses. The market seems to be treating this as a steady, low drama update rather than a breakout moment. The key point for investors is the widening gap between a partnership-driven top line and continuing net losses of more than US$60m for the quarter. With cash of about US$1.5b and no more collaboration revenue...

With S&P 500 futures pressing against a key resistance zone and traders watching for either a breakout or a sharp mean reversion, short-term moves in large-cap U.S. stocks are under an intense spotlight. This kind of setup can create sudden winners and sudden laggards, which is why it matters if you care about timing. This article walks through 3 stocks exposed to the current news-driven tension around profit-taking and potential pullbacks. The 3 stocks below are just a starting sample, and...

Boston Scientific (NYSE:BSX) has initiated multiple large-scale recalls of cardiac ablation and access devices affecting hundreds of thousands of units globally in late July and August 2026. An FDA enforcement report cites a software anomaly in the TheraSphere 360 radiological platform, adding to the recent wave of product safety actions. The cluster of recalls and the FDA software enforcement report comes shortly after Boston Scientific's latest earnings and guidance updates. Consider...

Maplebear (CART) is back in focus after fresh earnings projections and sentiment shifts, while its Instacart unit’s AI-powered Caper smart trolleys with UK grocer Morrisons add an extra angle to the stock’s story. See our latest analysis for Maplebear. At a share price of US$45.35, Maplebear has given investors a 90 day share price return of 19.37%, while the 1 year total shareholder return is down 4.97%. This suggests that recent momentum has picked up after a softer year. If you are...

With the Federal Reserve debating its next move and markets bracing for the possibility of higher rates, many investors are rethinking how they get reliable income from stocks. Rising borrowing costs and inflation worries can unsettle growth stories, yet they also shine a spotlight on companies that focus on steady dividends and durable cash flows. This article walks through three stocks from a Defensive Dividend Stocks screener that appear positively exposed to the current rate backdrop and...

Q2 earnings event puts Black Hills in focus Black Hills (BKH) is in the spotlight after reporting second quarter 2026 results on August 5, with higher net income and earnings per share from continuing operations compared with a year earlier. See our latest analysis for Black Hills. Despite Black Hills reporting higher net income and earnings per share for the quarter and affirming its quarterly dividend on July 28, the stock shows mixed momentum, with a 1-year total shareholder return of...

Datavault AI (DVLT) is back on investor screens after amending its agreement with DataMeds AI to expand PharmacyChain licensing into broader healthcare and wellness, while restructuring its stake into common shares categorized as revenue. See our latest analysis for Datavault AI. Despite the expanded DataMeds AI agreement and recent management and investor events, Datavault AI’s short term momentum remains weak, with the share price down 24% in the last day and 72% year to date, alongside...

Why Hartford Insurance Group stock is in focus now Hartford Insurance Group (HIG) is back on investor radar after reporting second quarter 2026 results, updating its share repurchase activity and outlining a new buyback authorization alongside an acquisition in employee benefits. See our latest analysis for Hartford Insurance Group. Hartford Insurance Group’s latest earnings, buyback update and the planned acquisition of Equitable’s Employee Benefits business come after a period where the...

Douglas Emmett stock slipped 1.3% today to about US$11.80, which is a muted move for a real estate investment trust that just posted another quarter of unprofitable earnings. The emotional drag is clear. Investors are fixating on the reported loss per share and the weight of higher interest costs, while the core real estate engine tells a more balanced story. The real action sits in funds from operations and cash generation. Funds From Operations held in the mid US$70m range in the quarter...

In the second quarter of 2026, Cleveland-Cliffs Inc. reported sales of US$5,226 million and a net loss of US$145 million, both improved from a year earlier, while executing no additional share repurchases under its April 2024 buyback program. The results show sales growth alongside a smaller loss per share, indicating that cost and operational measures are narrowing the company’s losses even as it pauses incremental buybacks. With quarterly losses narrowing and sales higher, we’ll now...

Callaway Golf stock slipped about 2% today, even though the quarter just delivered one of the cleanest margin stories the company has put up in a while. Revenue for Q2 came in at US$612.2m, but the real headline was profit quality, with net income from ongoing operations at US$75.8m and management highlighting a sharp lift in gross margin. Investors came into this print after a strong 90 day run in the stock, so expectations were high. The reaction suggests nerves about sustainability, not...

EVgo stock dropped about 12% to US$1.53 into Thursday, extending a weak 30 day stretch and setting a low bar for this earnings print. The market focused on the red ink, with Q2 2026 delivering a basic loss per share of US$0.15 and net loss of US$20.8m. Looking past the near term pain presents a different picture. Charging network revenue was US$61m, and management is guiding to US$400m to US$430m of revenue for 2026 with an adjusted EBITDA loss that could narrow by year end. This quarter...

On August 3, 2026, Helus Pharma appointed Michael Halstead as Chief Executive Officer, bringing 25 years of biopharma experience and a record of leading major drug launches, large-scale integrations and multi billion-dollar M&A transactions. Halstead’s history of guiding companies from clinical development to full commercial operations may signal a shift in how Helus Pharma approaches growth, partnerships and capital allocation. We’ll now explore how bringing in a CEO with extensive...